Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers June 26, 2016
Pharmacy Choice - News - Front Page Healthcare News - June 26, 2016

Pharmacy News

 Front Page Healthcare News
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

6/26/16 - Australia : New $200 Million Fund To Rebuild Regional Hospitals Open [TendersInfo (India)]
A new $200 million fund established by the Andrews Labor Government to rebuild rural and regional health facilities the largest of its kind in Victorian history is now open for applications. Minister for Health, Jill Hennessy, today urged health services across rural Victoria to apply for a share of $50 million from the first round of the new Regio
6/26/16 - Bevin's Medicaid proposal splits area lawmakers [Messenger-Inquirer, Owensboro, Ky.]
Matt Bevin to make changes to the state's Medicaid expansion, with some criticizing the announced changes, while others said revisions were necessary to save the entire Medicaid system. Medicaid was expanded by executive order as part of the Affordable Care Act, under then-Gov. The proposed changes apply only to "able-bodied adults" who enrolled in
6/26/16 - Canada : Saskatchewan's Cyclotron Now Supplying Radioisotopes to Royal University Hospital [TendersInfo (India)]
Stakeholders from government, health care and academia today marked the start of supply of radioisotopes from the Saskatchewan Centre for Cyclotron Sciences for patient PET-CT scans at Royal University Hospital. More Saskatchewan patients will now be able to receive PET-CT scans with a supply that comes from across the University of Saskatchewan ca
6/26/16 - Data in The Lancet Show Olaratumab Plus Doxorubicin Offered 11.8-Month Increase in Overall Survival in Patients with Advanced Soft Tissue Sarcoma, as...
Data in The Lancet Show Olaratumab Plus Doxorubicin Offered 11.8- Month Increase in Overall Survival in Patients with Advanced Soft Tissue Sarcoma, as Reported by Lilly and Memorial Sloan Kettering Researchers. By a News Reporter-Staff News Editor at Medical Letter on the CDC& FDA Eli Lilly and Company announced that The Lancet published detailed
6/26/16 - Investigators at Chongqing University Have Reported New Data on Autacoids (Identification of the inhibitory mechanism of FDA approved selective...
By a News Reporter-Staff News Editor at Medical Letter on the CDC& FDA Data detailed on Biological Factors have been presented. According to news reporting out of Chongqing, People's Republic of China, by NewsRx editors, research stated, "Antidepressants selectively inhibiting serotonin reuptake represent a highly effective drug class, and novel.
6/26/16 - New Osteomyelitis Study Findings Have Been Reported from University Hospital (Real-world daptomycin use across wide geographical regions: results...
New Osteomyelitis Study Findings Have Been Reported from University Hospital. By a News Reporter-Staff News Editor at Heart Disease Weekly Investigators publish new report on Musculoskeletal Diseases and Conditions. The news correspondents obtained a quote from the research from University Hospital, "Clinical success was defined as an outcome of'
6/26/16 - Northern Hospital receives Kate B. Reynolds Charitable Trust Grant
MOUNT AIRY Northern Hospital of Surry County announced it has received a $148,500 grant to provide a Diabetes Education and Self-Management Program from the Kate B. Reynolds Charitable Trust in Winston-Salem. The project will fund the expansion of the Diabetic Center of Excellence at Northern Family Medicine. The Diabetic Center of Excellence wa
6/26/16 - PhilHealth peritoneal dialysis first Z-benefit now available in Iloilo City [Philippines News Agency]
The Philippine Health Insurance Corporation has contracted the St. Paul's Hospital of Iloilo to become its first private hospital partner in the country to offer the peritoneal dialysis first Z benefit. Helen Caro-Pastolero, head of the kidney center of t the St. Paul's Hospital of Iloilo. With the Z benefit for PD first, PhilHealth has provided a
6/26/16 - Researchers from Veterans Affairs Medical Center Report on Findings in Heart Bypass Surgery (Short-term clinical outcomes after off-pump coronary...
According to news reporting out of Madison, Wisconsin, by NewsRx editors, research stated, "We retrospectively assessed the outcomes after coronary revascularization at a single Veterans Affairs Medical Center when a strategy of assigning higher risk patients to off-pump coronary artery bypass grafting was employed. Our news journalists obtained a
6/26/16 - Study Findings from Albert Einstein College of Medicine Provide New Insights into Heart Bypass Surgery (Transcatheter aortic valve replacement versus...
By a News Reporter-Staff News Editor at Heart Disease Weekly Investigators publish new report on Cardiology. According to news reporting out of Bronx, New York, by NewsRx editors, research stated, "Patients with severe aortic stenosis and previous coronary artery bypass graft surgery have increased risk for aortic valve replacement. Our news jour
6/26/16 - United Kingdom : Hikma acquires six injectable products in Europe [TendersInfo (India)]
Hikma Pharmaceuticals PLC, the fast growing multinational pharmaceutical group, announces that it has agreed to acquire a portfolio of six injectable products and their related customer contracts from Pfizer Inc.. The divestiture of these products was mandated by the European Commission as a condition to Pfizers acquisition of Hospira and the Europ
6/25/16 - Atara Bio Receives Advanced Therapy Medicinal Product Classification for Allogeneic Epstein-Barr Virus Specific Cytotoxic T-lymphocytes (EBV-CTLs)... [Daily News Egypt]
Atara Bio Receives Advanced Therapy Medicinal Product Classification for Allogeneic Epstein-Barr Virus Specific Cytotoxic T-lymphocytes from European Medicines Agency. -Atara Biotherapeutics, Inc., a biopharmaceutical company focused on developing meaningful therapies for patients with severe and life-threatening diseases, today announced...
6/25/16 - FDA Okays Trial for Medtronic's MRI-Guided Epilepsy Device [Daily Tribune (Bahrain)]
Medtronic plc MDT recently won the FDA's Investigational Device Exemption for the SLATE trial, which will evaluate this medical technology giant's Visualase MRI-Guided Laser Ablation technology. The SLATE study aims at enrolling 120 adult patients suffering from drug-resistant MTLE, who will be treated at selected epilepsy centers across the U.S. P
6/25/16 - INVESTOR ALERT: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit against Chiasma, Inc. and Reminds Investors with Losses to Contact the Firm
Khang& Khang LLP announces that a class action lawsuit has been filed against Chiasma, Inc.. The Company failed to disclose that the Phase 3 clinical trial for its oral octreotide, Mycapssa, which was conducted before the July 15, 2015 IPO, was insufficient to prove efficacy and secure FDA approval. On April 18, 2016 the Company announced that the
6/25/16 - SC requests solicitor general to consider on biosimilars [National Iraqi News Agency (Iraq)]
Novartis has crossed all of the legal hurdles and launched its biosimilar of Neupogen, but its patent fight with Amgen was extended when the Swiss drugmaker asked the U.S. Supreme Court to get involved. In question are a number of issues that are key to Novartis ambitious biosimilars plans going forward; those issues will determine in whose pocket,
6/25/16 - T3D Therapeutics Receives FDA Approval for a 6-Month, Open-Label Extension to its Phase 2a Trial of T3D-959 for Treatment of Mild to Moderate... [Seven Days (United Arab Emirates)]
-T3D Therapeutics, Inc., a clinical stage drug development company targeting Alzheimers disease, is announcing that the U.S. Food and Drug Administration has granted approval for a 26- week, open-label extension to its 2- week Phase 2 a clinical trial of T3D-959 in a limited number of subjects who completed the main Phase 2 a study for the treatmen
6/24/16 - 50 Health Ministry officials honoured [Daily Tribune (Bahrain)]
Manama: The Assistant Under-secretary for hospitals, Dr Walid Al Mana, has urged all the officials and employees to take care of sickle-cell patients by providing them best diagnosis, care and rehabilitation. The ceremony was organised under the auspices of Dr Walid Al Mana and the Department of Genetic blood diseases at Salmaniya Medical Centre as
6/24/16 - AppliedVR Brings Therapeutic Virtual Reality Content To Cedars-Sinai Medical Center [Global Data Point]
This does not require changing the face of healthcare, it merely requires AppliedVR's SaaS model for validated therapeutic VR content, to provide standardized and scalable technology that improves a patient's experience, "said Matthew Stoudt, Co-Founder and CEO of AppliedVR. Cedars-Sinai Medical Center is among the first hospitals to utilize scalab
6/24/16 - Aurora launches accountable care program with UnitedHealthCare [Jerusalem Post (Israel)]
UnitedHealthcare and Aurora Health Care are working together to help people receive more personalized and better connected care, which will significantly enhance peoples ability to live healthier lives, said Chris Abbott, CEO of UnitedHealthcare Medicare& Retirement in Wisconsin. The health care organization announced in April it had formed a...
6/24/16 - Blue Cross and Blue Shield of Louisiana projects to lose more than $200M on ACA individual plans [Cihan News Agency (Turkey)]
The result is that Blue Cross expects to lose in excess of $200 million in Louisiana on individual plans over a three-year-period ending this year. That leaves Blue Cross with massive uncertainty, as it must set policy rates in March of each year for the following year. So if Udvarhelyis prediction is right and the ACA is not structurally changed u
6/24/16 - Boehringer Ingelheim and HealthPrize Partner to Launch New Support Program for People Treating COPD With SPIRIVA RESPIMAT tiotropium bromide...
Boehringer Ingelheim and HealthPrize Partner to Launch New Support Program for People Treating COPD With SPIRIVA RESPIMAT tiotropium bromide Inhalation Spray. By a News Reporter-Staff News Editor at Drug Week Boehringer Ingelheim Pharmaceuticals Inc. and HealthPrize Technologies announced the launch of RespiPoints?, a free online program
6/24/16 - Cardiome Pharma Corp. Announces Voting Results
-Cardiome Pharma Corp. today announced the results of voting at its 2016 Annual General Meeting of Shareholders held on June 21, 2016. About Cardiome Pharma Corp. Cardiome Pharma Corp. is a specialty pharmaceutical company dedicated to the development and commercialization of cardiovascular therapies that will improve the quality of life and health
6/24/16 - Data on Abscess Described by Researchers at Emory University Hospital (The Use of Facial CT for the Evaluation of a Suspected Simple Dentoalveolar...
Data on Abscess Described by Researchers at Emory University Hospital. According to news reporting originating from Atlanta, Georgia, by NewsRx correspondents, research stated, "Facial computed tomography is often performed in the emergency department as a part of the diagnostic workup for patients presenting with the signs and symptoms of dentoalv
6/24/16 - DaVita Announces Intent to Enter into Transaction with Inspira Health Network to Provide Dialysis Services
By a News Reporter-Staff News Editor at Health& Medicine Week DaVita Kidney Care, a division of DaVita HealthCare Partners, announced its intent to enter into a joint venture acquisition with Inspira Health Network that will bring DaVita's industry-leading quality patient care to Southern New Jersey. The proposed joint venture would transfer majo
6/24/16 - Endocure Technologies, Inc., A Wholly Owned Subsidiary Of MedServ Technologies, Inc., Has Received FDA 510k Clearance For The Manufacture Of Its New...
Endocure Technologies, Inc., A Wholly Owned Subsidiary Of MedServ Technologies, Inc., Has Received FDA 510 k Clearance For The Manufacture Of Its New Endocure Model EUR078A Urology Endoscope. By a News Reporter-Staff News Editor at Health& Medicine Week Endocure Technologies, Inc., our medical R&D and OEM company, has received FDA 510 clearance f
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2016 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comRxProHealth.comNursingJobSource.comNurseZone.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415